Stocktoria
Perspective Therapeutics, Inc. CATX
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2002-05-31
Perspective Therapeutics, Inc. financials (annual, from 10-K)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.4M | $0 | $10.8M | $10.1M | $9.7M | $7.3M | $5.9M | $4.8M |
| Gross profit | — | — | $1.4M | $0 | $0 | $5.1M | $5.1M | $3.0M | $1.8M | $838,000 |
| R&D expense | $84.2M | $41.6M | $21.3M | $881,000 | $850,000 | $1.4M | $1.1M | $1.5M | $1.7M | $965,000 |
| Operating income | -$113.6M | -$90.9M | -$40.9M | -$8.7M | -$6.4M | -$3.4M | -$3.5M | -$5.3M | -$6.7M | -$6.3M |
| Interest expense | — | — | $84,000 | $0 | $0 | — | — | — | — | $0 |
| Income tax | -$793,000 | -$2.1M | -$2.7M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$103.1M | -$79.3M | -$46.5M | -$10.8M | -$7.3M | -$3.4M | -$3.4M | -$5.1M | -$6.7M | -$6.2M |
| EPS (diluted) | $-1.40 | $-1.23 | $-1.74 | — | — | — | — | — | — | — |
| Operating cash flow | -$82.5M | -$18.3M | -$36.9M | -$10.4M | -$7.7M | -$2.8M | -$3.6M | -$5.0M | -$5.7M | -$5.7M |
| Free cash flow | -$95.2M | -$72.7M | -$38.0M | -$10.7M | -$8.0M | -$3.2M | -$3.9M | -$5.5M | -$6.0M | -$6.3M |
| Cash & equivalents | $30.6M | $61.6M | $9.2M | $21.0M | $55.9M | $63.8M | $2.4M | $5.3M | $2.6M | $5.9M |
| Inventory | — | — | — | $1.4M | $1.4M | $980,000 | $645,000 | $530,000 | $494,000 | $323,000 |
| Total assets | $267.0M | $341.1M | $97.9M | $58.1M | $64.4M | $70.4M | $8.7M | $9.4M | $7.5M | $12.3M |
| Total liabilities | $59.9M | $50.4M | $22.7M | $3.4M | $3.2M | $3.0M | $3.0M | $1.7M | $2.4M | $1.7M |
| Shareholders' equity | $207.0M | $290.7M | $75.2M | $54.6M | $61.3M | $67.4M | $5.7M | $7.7M | $5.0M | $10.6M |
Growth · year-over-year · Revenue CAGR -15.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | -100.0% | +7.4% | +3.9% | +32.3% | +23.5% | +24.4% | -0.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000728387 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.